213 related articles for article (PubMed ID: 32555371)
21. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
[TBL] [Abstract][Full Text] [Related]
22. Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
Hsu J; Artz A; Mayer SA; Guarner D; Bishop MR; Reich-Slotky R; Smith SM; Greenberg J; Kline J; Ferrante R; Phillips AA; Gergis U; Liu H; Stock W; Cushing M; Shore TB; van Besien K
Biol Blood Marrow Transplant; 2018 Feb; 24(2):359-365. PubMed ID: 29128555
[TBL] [Abstract][Full Text] [Related]
23. Cord blood chimerism and relapse after haplo-cord transplantation.
van Besien K; Koshy N; Gergis U; Mayer S; Cushing M; Rennert H; Reich-Slotky R; Mark T; Pearse R; Rossi A; Phillips A; Vasovic L; Ferrante R; Hsu YM; Shore T
Leuk Lymphoma; 2017 Feb; 58(2):288-297. PubMed ID: 27333804
[TBL] [Abstract][Full Text] [Related]
24. Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.
Lister J; Gryn JF; McQueen KL; Harris DT; Rossetti JM; Shadduck RK
Stem Cells Dev; 2007 Feb; 16(1):177-86. PubMed ID: 17348813
[TBL] [Abstract][Full Text] [Related]
25. T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin.
Jakubowski AA; Small TN; Young JW; Kernan NA; Castro-Malaspina H; Hsu KC; Perales MA; Collins N; Cisek C; Chiu M; van den Brink MR; O'Reilly RJ; Papadopoulos EB
Blood; 2007 Dec; 110(13):4552-9. PubMed ID: 17717135
[TBL] [Abstract][Full Text] [Related]
26. Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
Tsai SB; Liu H; Shore T; Fan Y; Bishop M; Cushing MM; Gergis U; Godley L; Kline J; Larson RA; Martinez G; Mayer S; Odenike O; Stock W; Wickrema A; van Besien K; Artz AS
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1065-1072. PubMed ID: 26912055
[TBL] [Abstract][Full Text] [Related]
27. Cord blood transplants supported by unrelated donor CD34
Gomez-Arteaga A; Orfali N; Guarneri D; Cushing MM; Gergis U; Hsu J; Hsu YS; Mayer SA; Phillips AA; Chase SA; Mokhtar AE; Shore TB; Van Besien K
Bone Marrow Transplant; 2020 Dec; 55(12):2298-2307. PubMed ID: 32518291
[TBL] [Abstract][Full Text] [Related]
28. High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.
Baron F; Maris MB; Storer BE; Sandmaier BM; Panse JP; Chauncey TR; Sorror M; Little MT; Maloney DG; Storb R; Heimfeld S
Leukemia; 2005 May; 19(5):822-8. PubMed ID: 15772701
[TBL] [Abstract][Full Text] [Related]
29. Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34
Scordo M; Bhatt V; Hilden P; Smith M; Thoren K; Cho C; Shah GL; Maloy MA; Papadopoulos EB; Jakubowski AA; Avecilla ST; O'Reilly RJ; Castro-Malaspina H; Tamari R; Shaffer BC; Boelens JJ; Perales MA; Giralt SA
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1526-1535. PubMed ID: 30831208
[TBL] [Abstract][Full Text] [Related]
30. Haploidentical hematopoietic stem cell transplantation in hematologic malignancies with G-CSF mobilized bone marrow plus peripheral blood stem cells grafts without T cell depletion: a single center report of 29 cases.
Wang HX; Yan HM; Wang ZD; Xue M; Liu J; Guo ZK
Leuk Lymphoma; 2012 Apr; 53(4):654-9. PubMed ID: 21929286
[TBL] [Abstract][Full Text] [Related]
31. Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation.
Purtill D; Stevens CE; Lubin M; Ponce D; Hanash A; Giralt S; Scaradavou A; Young JW; Barker JN
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1981-4. PubMed ID: 26211983
[TBL] [Abstract][Full Text] [Related]
32. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation.
Matsuno N; Wake A; Uchida N; Ishiwata K; Araoka H; Takagi S; Tsuji M; Yamamoto H; Kato D; Matsuhashi Y; Seo S; Masuoka K; Miyakoshi S; Makino S; Yoneyama A; Kanda Y; Taniguchi S
Blood; 2009 Aug; 114(8):1689-95. PubMed ID: 19535797
[TBL] [Abstract][Full Text] [Related]
33. [Outcome of combination of HLA-haploidentical hematopoietic SCT with an unrelated cord blood unit for 127 patients with acquired severe aplastic anemia].
Liu LM; Zhang YM; Zhou HF; Wang QY; Qiu HY; Tang XW; Han Y; Fu CC; Jin ZM; Sun AN; Miao M; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2018 Aug; 39(8):624-628. PubMed ID: 30180460
[No Abstract] [Full Text] [Related]
34. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults.
Hamza NS; Lisgaris M; Yadavalli G; Nadeau L; Fox R; Fu P; Lazarus HM; Koc ON; Salata RA; Laughlin MJ
Br J Haematol; 2004 Feb; 124(4):488-98. PubMed ID: 14984500
[TBL] [Abstract][Full Text] [Related]
35. A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin.
Nishida T; Kobayashi T; Sawa M; Masuda S; Shibasaki Y; Goto T; Fukuhara N; Fujii N; Ikegame K; Sugita J; Ikeda T; Kuwatsuka Y; Suzuki R; Najima Y; Doki N; Kato T; Inagaki Y; Utsu Y; Aotsuka N; Masuko M; Terakura S; Onishi Y; Maeda Y; Okada M; Teshima T; Murata M
Ann Hematol; 2021 Mar; 100(3):743-752. PubMed ID: 33427909
[TBL] [Abstract][Full Text] [Related]
36. Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies.
Law AD; Salas MQ; Lam W; Michelis FV; Thyagu S; Kim DDH; Lipton JH; Kumar R; Messner H; Viswabandya A
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2259-2264. PubMed ID: 30009980
[TBL] [Abstract][Full Text] [Related]
37. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
Gaballa S; Ge I; El Fakih R; Brammer JE; Kongtim P; Tomuleasa C; Wang SA; Lee D; Petropoulos D; Cao K; Rondon G; Chen J; Hammerstrom A; Lombardi L; Alatrash G; Korbling M; Oran B; Kebriaei P; Ahmed S; Shah N; Rezvani K; Marin D; Bashir Q; Alousi A; Nieto Y; Qazilbash M; Hosing C; Popat U; Shpall EJ; Khouri I; Champlin RE; Ciurea SO
Cancer; 2016 Nov; 122(21):3316-3326. PubMed ID: 27404668
[TBL] [Abstract][Full Text] [Related]
38. Cord blood transplantation for adult patients with hematological malignancies.
Yamane T; Nakamae H; Hasegawa T; Terada Y; Hagihara K; Ohta K; Hino M
Osaka City Med J; 2005 Dec; 51(2):83-8. PubMed ID: 16617685
[TBL] [Abstract][Full Text] [Related]
39. No impact of total or myeloid Cd34+ cell numbers on neutrophil engraftment and transplantation-related mortality after allogeneic pediatric bone marrow transplantation.
Pichler H; Witt V; Winter E; Boztug H; Glogova E; Pötschger U; Matthes-Martin S; Fritsch G
Biol Blood Marrow Transplant; 2014 May; 20(5):676-83. PubMed ID: 24492145
[TBL] [Abstract][Full Text] [Related]
40. An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment.
Eldjerou LK; Chaudhury S; Baisre-de Leon A; He M; Arcila ME; Heller G; O'Reilly RJ; Barker JN; Moore MA
Blood; 2010 Nov; 116(19):3999-4006. PubMed ID: 20587781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
